Literature DB >> 17010639

Development of leptin antagonists and their potential use in experimental biology and medicine.

Arieh Gertler1.   

Abstract

Leptin is a pleotropic hormone that acts both centrally and peripherally. Whereas leptin exhibits positive effects on several physiological functions, such as regulation of energy metabolism, reproductive function and immune responses, negative actions, such as enhancement of undesired immune responses in autoimmune diseases, tumorigenesis, elevated blood pressure and cardiovascular pathologies, have also been documented. The recent development of leptin muteins with antagonistic properties and other proteins that block leptin activity opens up new possibilities for their use in research and, eventually, therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010639     DOI: 10.1016/j.tem.2006.09.006

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  25 in total

1.  Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.

Authors:  Dan Yan; Dimiter Avtanski; Neeraj K Saxena; Dipali Sharma
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

2.  Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.

Authors:  Su-Hyeong Kim; Arumugam Nagalingam; Neeraj K Saxena; Shivendra V Singh; Dipali Sharma
Journal:  Carcinogenesis       Date:  2010-12-16       Impact factor: 4.944

3.  Development and characterization of high affinity leptins and leptin antagonists.

Authors:  Michal Shpilman; Leonora Niv-Spector; Meirav Katz; Chen Varol; Gili Solomon; Michal Ayalon-Soffer; Eric Boder; Zamir Halpern; Eran Elinav; Arieh Gertler
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

Review 4.  The multifactorial role of leptin in driving the breast cancer microenvironment.

Authors:  Sebastiano Andò; Stefania Catalano
Journal:  Nat Rev Endocrinol       Date:  2011-11-15       Impact factor: 43.330

5.  Effects of intrauterine undernutrition on hypothalamic Kiss1 expression and the timing of puberty in female rats.

Authors:  T Iwasa; T Matsuzaki; M Murakami; S Fujisawa; R Kinouchi; G Gereltsetseg; A Kuwahara; T Yasui; M Irahara
Journal:  J Physiol       Date:  2010-01-18       Impact factor: 5.182

Review 6.  Emerging role of leptin in rheumatoid arthritis.

Authors:  G Tian; J-N Liang; Z-Y Wang; D Zhou
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

Review 7.  PI3K signaling: A key pathway in the control of sympathetic traffic and arterial pressure by leptin.

Authors:  Shannon M Harlan; Kamal Rahmouni
Journal:  Mol Metab       Date:  2013-03-23       Impact factor: 7.422

8.  A leptin-mediated central mechanism in analgesia-enhanced opioid reward in rats.

Authors:  Grewo Lim; Hyangin Kim; Michael F McCabe; Chiu-Wen Chou; Shuxing Wang; Lucy L Chen; John J A Marota; Anne Blood; Hans C Breiter; Jianren Mao
Journal:  J Neurosci       Date:  2014-07-16       Impact factor: 6.167

9.  Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents.

Authors:  Grewo Lim; Shuxing Wang; Yi Zhang; Yinghong Tian; Jianren Mao
Journal:  J Clin Invest       Date:  2009-01-12       Impact factor: 14.808

10.  Positive regulatory control loop between gut leptin and intestinal GLUT2/GLUT5 transporters links to hepatic metabolic functions in rodents.

Authors:  Yassine Sakar; Corinne Nazaret; Philippe Lettéron; Amal Ait Omar; Mathilde Avenati; Benoît Viollet; Robert Ducroc; André Bado
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.